Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) CEO John Treace bought 29,430 shares of the company’s stock in a transaction on Wednesday, June 10th. The stock was bought at an average price of $4.02 per share, with a total value of $118,308.60. Following the completion of the acquisition, the chief executive officer owned […]

Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) CEO John Treace acquired 29,430 shares of the company’s stock in a transaction on Wednesday, June 10th. The stock was acquired at an average cost of $4.02 per share, with a total value of $118,308.60. Following the completion of the purchase, the chief executive officer directly […]

Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) CEO John Treace bought 50,000 shares of the stock in a transaction on Monday, June 1st. The shares were purchased at an average price of $3.56 per share, with a total value of $178,000.00. Following the acquisition, the chief executive officer owned 7,323,833 shares in the […]